- Tytuł:
-
Safety and Effectiveness of Peficitinib (ASP015K) in Patients with
Rheumatoid Arthritis : Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan - Autorzy:
- Źródło:
- Rheumatology and Therapy. 8(1):425-442
Czasopismo naukowe